Johnson & Johnson stock slides despite company's projected $100 billion annual sales - Fox Business
Johnson & Johnson stock slides despite company's projected $100 billion annual sales Fox Business
Johnson & Johnson Company News
J&J posts weak medical device sales, shares fall - Reuters
J&J posts weak medical device sales, shares fall Reuters
J&J Is Leaning Toward Spinning Out Its Hips-And-Knees Business - WSJ
J&J Is Leaning Toward Spinning Out Its Hips-And-Knees Business WSJ
Johnson & Johnson stock falls despite strong earnings as investors focus on medtech unit - Yahoo Finance
Johnson & Johnson stock falls despite strong earnings as investors focus on medtech unit Yahoo Finance
Johnson and Johnson Earnings Report | 2026 Q3 Infographic - Johnson & Johnson
Johnson and Johnson Earnings Report | 2026 Q3 Infographic Johnson & Johnson
Johnson & Johnson CFO Joseph Wolk on the company’s Q3 results - CNBC
Johnson & Johnson CFO Joseph Wolk on the company’s Q3 results CNBC
Johnson &Johnson Stock Earnings: Can a Spinoff Fix Its Medtech Problem - Barron's
Johnson &Johnson Stock Earnings: Can a Spinoff Fix Its Medtech Problem Barron's
Johnson & Johnson MedTech sets mid-2027 target for ortho spinoff, as Q3 device sales disappoint - MassDevice
Johnson & Johnson MedTech sets mid-2027 target for ortho spinoff, as Q3 device sales disappoint MassDevice
Johnson & Johnson leaning toward spinning out hips-and-knees business - WSJ (JNJ:NYSE) - Seeking Alpha
Johnson & Johnson leaning toward spinning out hips-and-knees business - WSJ (JNJ:NYSE) Seeking Alpha
J&J posts weak medical device sales, shares fall - CNBC
J&J posts weak medical device sales, shares fall CNBC
Johnson & Johnson (JNJ) Sees $107.4 Million in Net ETF Buying on Wednesday - Yahoo Finance
Johnson & Johnson (JNJ) Sees $107.4 Million in Net ETF Buying on Wednesday Yahoo Finance
Johnson & Johnson CFO taps internal investment for medtech growth - CFO Dive
Johnson & Johnson CFO taps internal investment for medtech growth CFO Dive
J&J’s medtech business slows again in Q3 - MedTech Dive
J&J’s medtech business slows again in Q3 MedTech Dive
Johnson & Johnson reports mixed Q3 earnings - Healthcare Brew
Johnson & Johnson reports mixed Q3 earnings Healthcare Brew
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance - Business Wire
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance Business Wire
Where Could Johnson & Johnson’s Next Growth Come From? - Trefis
Where Could Johnson & Johnson’s Next Growth Come From? Trefis
Johnson & Johnson raises profit guidance in Q3 2026 earnings - Quartz
Johnson & Johnson raises profit guidance in Q3 2026 earnings Quartz
Johnson & Johnson Q3 2026 earnings: CEO and CFO prepared remarks - Johnson & Johnson
Johnson & Johnson Q3 2026 earnings: CEO and CFO prepared remarks Johnson & Johnson
Johnson & Johnson's Enterprise Review Expected to Sharpen Outlook, Morgan Stanley Says - Yahoo Finance
Johnson & Johnson's Enterprise Review Expected to Sharpen Outlook, Morgan Stanley Says Yahoo Finance
Johnson & Johnson's Upgraded Full-Year Outlook Misses Wall Street Views; Stock Declines - Yahoo Finance
Johnson & Johnson's Upgraded Full-Year Outlook Misses Wall Street Views; Stock Declines Yahoo Finance
Johnson & Johnson Beats Third-Quarter Earnings Estimates and Raises 2026 Revenue and Profit Outlook - Yahoo Finance
Johnson & Johnson Beats Third-Quarter Earnings Estimates and Raises 2026 Revenue and Profit Outlook Yahoo Finance
The Open Question Under Johnson & Johnson Stock’s Price - Trefis
The Open Question Under Johnson & Johnson Stock’s Price Trefis
Why Johnson & Johnson Stock Dropped Today - The Motley Fool
Why Johnson & Johnson Stock Dropped Today The Motley Fool
Johnson and Johnson Stock Plunges 6% As Medical Device Sales Miss Wall Street Forecasts - TIKR.com
Johnson and Johnson Stock Plunges 6% As Medical Device Sales Miss Wall Street Forecasts TIKR.com
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026 - Business Wire
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026 Business Wire
Johnson & Johnson shares fall following earnings - CNBC
Johnson & Johnson shares fall following earnings CNBC
Johnson & Johnson Reports Q3 2026 Results, Raises Full-Year Guidance - VisionMonday.com
Johnson & Johnson Reports Q3 2026 Results, Raises Full-Year Guidance VisionMonday.com
What Johnson & Johnson (JNJ) Said on Its Q3 Earnings Call - Yahoo Finance
What Johnson & Johnson (JNJ) Said on Its Q3 Earnings Call Yahoo Finance
Johnson & Johnson: Stop Paying A Premium For Disappointment - Strong Sell (NYSE:JNJ) - Seeking Alpha
Johnson & Johnson: Stop Paying A Premium For Disappointment - Strong Sell (NYSE:JNJ) Seeking Alpha
Johnson & Johnson: Keep Calm And Hold On (NYSE:JNJ) - Seeking Alpha
Johnson & Johnson: Keep Calm And Hold On (NYSE:JNJ) Seeking Alpha
Johnson & Johnson mulls spinning off orthopedics business as medtech sales disappoint - Yahoo Finance Singapore
Johnson & Johnson mulls spinning off orthopedics business as medtech sales disappoint Yahoo Finance Singapore
Earnings call transcript: Johnson & Johnson tops Q3 2026 EPS forecast, shares fall - Investing.com
Earnings call transcript: Johnson & Johnson tops Q3 2026 EPS forecast, shares fall Investing.com
Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff - 24/7 Wall St.
Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff 24/7 Wall St.
Johnson & Johnson Q3 Earnings: Talc Resolution Offer Impacts Earnings, MedTech Slows Growth - Seeking Alpha
Johnson & Johnson Q3 Earnings: Talc Resolution Offer Impacts Earnings, MedTech Slows Growth Seeking Alpha
Johnson & Johnson (JNJ) Stock Rebounds While Earnings Power Keeps Eroding - Simply Wall Street
Johnson & Johnson (JNJ) Stock Rebounds While Earnings Power Keeps Eroding Simply Wall Street
Johnson & Johnson Q3 Sets 'Negative Tone For Broader Pharma Sector': Analysts - Benzinga
Johnson & Johnson Q3 Sets 'Negative Tone For Broader Pharma Sector': Analysts Benzinga
Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool
Johnson & Johnson (JNJ) Q3 Earnings Surpass Estimates - Yahoo Finance
Johnson & Johnson (JNJ) Q3 Earnings Surpass Estimates Yahoo Finance
Johnson & Johnson Stock Has Surged 44%, Can Its Growth Justify the Valuation? - Yahoo Finance
Johnson & Johnson Stock Has Surged 44%, Can Its Growth Justify the Valuation? Yahoo Finance
J&J Beat and Raised. The Stock Fell Anyway. Here’s What the Target Says - 24/7 Wall St.
J&J Beat and Raised. The Stock Fell Anyway. Here’s What the Target Says 24/7 Wall St.